UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

MUC1 attenuates neutrophilic airway inflammation in asthma by reducing NLRP3 inflammasome-mediated pyroptosis through the inhibition of the TLR4/MyD88/NF-κB pathway

Respiratory research, 2023-10, Vol.24 (1), p.1-255, Article 255

2023

Volltextzugriff (PDF)

Standardized thresholds of volume-based PET/CT parameters predicting survival of patients with pancreatic head cancer treated with stereotactic body radiation therapy

Annals of nuclear medicine, 2020-06, Vol.34 (6), p.379-387

2020

Volltextzugriff (PDF)

Radiosensitization of human pancreatic cancer by piperlongumine analogues

Chinese chemical letters, 2021-03, Vol.32 (3), p.1197-1201

2021

Volltextzugriff (PDF)

Necroptosis in Pulmonary Diseases: A New Therapeutic Target

Frontiers in pharmacology, 2021-09, Vol.12, p.737129-737129

2021

Volltextzugriff (PDF)

Correction: Efficacy and toxicity of stereotactic body radiotherapy for un-resectable stage III non-small cell lung cancer patients unfit for concurrent chemoradiation therapy: a retrospective study

Radiation oncology (London, England), 2023-10, Vol.18 (1), p.1-169, Article 169

2023

Volltextzugriff (PDF)

Clinical efficacy of Stereotactic Body Radiation Therapy (SBRT) for adrenal gland metastases: A multi-center retrospective study from China

Scientific reports, 2020-05, Vol.10 (1), p.7836, Article 7836

2020

Volltextzugriff (PDF)

Two-institution results of Stereotactic Body Radiation Therapy (SBRT) for treating adrenal gland metastases from liver cancer

BMC cancer, 2023-01, Vol.23 (1), p.73-9, Article 73

2023

Volltextzugriff (PDF)

Stereotactic body radiation therapy for the primary tumor and oligometastases versus the primary tumor alone in patients with metastatic pancreatic cancer

Radiation oncology (London, England), 2024-08, Vol.19 (1), p.111-9

2024

Volltextzugriff (PDF)

Stereotactic body radiotherapy (SBRT) versus androgen deprivation therapy (ADT) for oligometastatic prostate cancer: protocol for a prospective randomised control clinical trial

BMJ open, 2022-09, Vol.12 (9), p.e051371-e051371

2022

Volltextzugriff (PDF)

Five-year outcomes of stereotactic body radiation therapy (SBRT) for prostate cancer: the largest experience in China

Journal of cancer research and clinical oncology, 2021-12, Vol.147 (12), p.3557-3564

2021

Volltextzugriff (PDF)

The Role of FABP5 in Radiation-Induced Human Skin Fibrosis

Radiation research, 2018-02, Vol.189 (2), p.177

2018

Volltextzugriff (PDF)

Dose evaluations of organs at risk and predictions of gastrointestinal toxicity after re-irradiation with stereotactic body radiation therapy for pancreatic cancer by deformable image registration

Frontiers in oncology, 2023-01, Vol.12, p.1021058-1021058

2023

Volltextzugriff (PDF)

Phase I study of dose‐escalated stereotactic body radiation therapy for locally advanced pancreatic head cancers: Initial clinical results

Cancer medicine (Malden, MA), 2021-10, Vol.10 (19), p.6736-6743

2021

Volltextzugriff (PDF)

Biologically effective doses of 60–70Gy versus >70Gy of stereotactic body radiotherapy (SBRT) combined with chemotherapy in locally advanced pancreatic cancer: protocol of a single-centre, phase II clinical trial

BMJ open, 2022-08, Vol.12 (8), p.e049382-e049382

2022

Volltextzugriff (PDF)

Protocol for Evaluating the Efficacy and Safety of Radiotherapy for Prostate and Oligometastatic Lesions in Patients With Low-Burden Sensitive Oligometastatic Prostate Cancer: An Open, Exploratory Pilot Clinical Trial

Cancer control, 2024-08, Vol.31, p.10732748241274595

2024

Volltextzugriff (PDF)

Efficacy and toxicity of stereotactic body radiotherapy for un-resectable stage III non-small cell lung cancer patients unfit for concurrent chemoradiation therapy: a retrospective study

Radiation oncology (London, England), 2023-08, Vol.18 (1), p.1-140, Article 140

2023

Volltextzugriff (PDF)

Neoadjuvant radiohormonal therapy for oligo-metastatic prostate cancer: safety and efficacy outcomes from an open-label, dose-escalation, single-center, phase I/II clinical trial

Frontiers of medicine, 2023-04, Vol.17 (2), p.231-239

2023

Volltextzugriff (PDF)

Using optimal controlled singlet spin order to accurately target molecular signal in MRI and MRS

Scientific reports, 2023-02, Vol.13 (1), p.2212-2212, Article 2212

2023

Volltextzugriff (PDF)

Personalized designs of adjuvant radiotherapy for pancreatic cancer based on molecular profiles

Cancer science, 2021-01, Vol.112 (1), p.287-295

2021

Volltextzugriff (PDF)

Failure patterns and outcomes of dose escalation of stereotactic body radiotherapy for locally advanced pancreatic cancer: a multicenter cohort study

Therapeutic advances in medical oncology, 2020, Vol.12, p.1758835920977155-1758835920977155

2020

Volltextzugriff (PDF)

Prognostic utility of blood inflammation biomarkers before and after treatment on the survival of patients with locally advanced non‐small cell lung cancer undergoing stereotactic body radiotherapy

The clinical respiratory journal, 2024-05, Vol.18 (5), p.e13749-n/a

2024

Volltextzugriff (PDF)

Dosimetric and biological comparisons of single planning and double plannings for bilateral lung cancer SBRT planning based on the Cyber-Knife system

Frontiers in oncology, 2022-11, Vol.12, p.1015999-1015999

2022

Volltextzugriff (PDF)

Correlation between morphological parameters and dosimetric parameters of the heart and spinal cord in the intermediate‐ and advanced‐stage esophageal cancer

Cancer reports, 2024-03, Vol.7 (3), p.e2015-n/a

2024

Volltextzugriff (PDF)

Short-term outcomes and clinical efficacy of stereotactic body radiation therapy (SBRT) in treatment of adrenal gland metastases from lung cancer

Radiation oncology (London, England), 2018-10, Vol.13 (1), p.205-8, Article 205

2018

Volltextzugriff (PDF)

Comparisons of different neoadjuvant chemotherapy regimens with or without stereotactic body radiation therapy for borderline resectable pancreatic cancer: study protocol of a prospective, randomized phase II trial (BRPCNCC-1)

Radiation oncology (London, England), 2019-03, Vol.14 (1), p.52-52, Article 52

2019

Volltextzugriff (PDF)

1 – 25 von 127

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(115)
Mit Volltextzugriff
(116)

Publikationsform

Sprache

Englisch
(125)
Chinesisch
(2)

Erscheinungsjahr

n.n

Thema

Science & Technology
(98)
Life Sciences & Biomedicine
(86)
Oncology
(47)
Humans
(43)
Radiation Therapy
(29)
Pancreatic Cancer
(25)
Cancer Therapies
(23)
Male
(23)
Female
(20)
Metastasis
(20)
Radiology, Nuclear Medicine & Medical Imaging
(19)
Chemotherapy
(18)
Radiotherapy
(18)
Stereotactic Body Radiation Therapy
(18)
Middle Aged
(17)
Patients
(16)
Aged
(15)
Toxicity
(14)
Medical Prognosis
(13)
Tumors
(13)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

MUC1 attenuates neutrophilic airway inflammation in asthma by reducing NLRP3 inflammasome-mediated pyroptosis through the inhibition of the TLR4/MyD88/NF-κB pathway

Standardized thresholds of volume-based PET/CT parameters predicting survival of patients with pancreatic head cancer treated with stereotactic body radiation therapy

Radiosensitization of human pancreatic cancer by piperlongumine analogues

Necroptosis in Pulmonary Diseases: A New Therapeutic Target

Correction: Efficacy and toxicity of stereotactic body radiotherapy for un-resectable stage III non-small cell lung cancer patients unfit for concurrent chemoradiation therapy: a retrospective study

Clinical efficacy of Stereotactic Body Radiation Therapy (SBRT) for adrenal gland metastases: A multi-center retrospective study from China

Two-institution results of Stereotactic Body Radiation Therapy (SBRT) for treating adrenal gland metastases from liver cancer

Stereotactic body radiation therapy for the primary tumor and oligometastases versus the primary tumor alone in patients with metastatic pancreatic cancer

Stereotactic body radiotherapy (SBRT) versus androgen deprivation therapy (ADT) for oligometastatic prostate cancer: protocol for a prospective randomised control clinical trial

Five-year outcomes of stereotactic body radiation therapy (SBRT) for prostate cancer: the largest experience in China

The Role of FABP5 in Radiation-Induced Human Skin Fibrosis

Dose evaluations of organs at risk and predictions of gastrointestinal toxicity after re-irradiation with stereotactic body radiation therapy for pancreatic cancer by deformable image registration

Phase I study of dose‐escalated stereotactic body radiation therapy for locally advanced pancreatic head cancers: Initial clinical results

Biologically effective doses of 60–70Gy versus >70Gy of stereotactic body radiotherapy (SBRT) combined with chemotherapy in locally advanced pancreatic cancer: protocol of a single-centre, phase II clinical trial

Protocol for Evaluating the Efficacy and Safety of Radiotherapy for Prostate and Oligometastatic Lesions in Patients With Low-Burden Sensitive Oligometastatic Prostate Cancer: An Open, Exploratory Pilot Clinical Trial

Efficacy and toxicity of stereotactic body radiotherapy for un-resectable stage III non-small cell lung cancer patients unfit for concurrent chemoradiation therapy: a retrospective study

Neoadjuvant radiohormonal therapy for oligo-metastatic prostate cancer: safety and efficacy outcomes from an open-label, dose-escalation, single-center, phase I/II clinical trial

Using optimal controlled singlet spin order to accurately target molecular signal in MRI and MRS

Personalized designs of adjuvant radiotherapy for pancreatic cancer based on molecular profiles

Failure patterns and outcomes of dose escalation of stereotactic body radiotherapy for locally advanced pancreatic cancer: a multicenter cohort study

Prognostic utility of blood inflammation biomarkers before and after treatment on the survival of patients with locally advanced non‐small cell lung cancer undergoing stereotactic body radiotherapy

Dosimetric and biological comparisons of single planning and double plannings for bilateral lung cancer SBRT planning based on the Cyber-Knife system

Correlation between morphological parameters and dosimetric parameters of the heart and spinal cord in the intermediate‐ and advanced‐stage esophageal cancer

Short-term outcomes and clinical efficacy of stereotactic body radiation therapy (SBRT) in treatment of adrenal gland metastases from lung cancer

Comparisons of different neoadjuvant chemotherapy regimens with or without stereotactic body radiation therapy for borderline resectable pancreatic cancer: study protocol of a prospective, randomized phase II trial (BRPCNCC-1)

Suchergebnisse filtern